VOYA Investment Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.7K | Buy |
|
|||||
|
2025
Q1 | $76K | Sell |
|
|||||
|
2024
Q4 | $129K | Sell |
|
|||||
|
2024
Q3 | $104K | Buy |
|
|||||
|
2024
Q2 | $140K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $44.6K | Hold |
|
|||||
|
2022
Q4 | $175K | Buy |
|
|||||
|
2022
Q3 | $178K | Buy |
|
|||||
|
2022
Q2 | $155K | Sell |
|
|||||
|
2022
Q1 | $220K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $128K | Hold |
|
|||||
|
2021
Q2 | $224K | Sell |
|
|||||
|
2021
Q1 | $330K | Buy |
|
|||||
|
2020
Q4 | $290K | Buy |
|
|||||
|
2020
Q3 | $331K | Hold |
|
|||||
|
2020
Q2 | $457K | Sell |
|
|||||
|
2020
Q1 | $398K | Buy |
|
|||||
|
2019
Q4 | $731K | Buy |
|
|||||
|
2019
Q3 | $357K | Hold |
|
|||||
|
2019
Q2 | $452K | Buy |
|
|||||
|
2019
Q1 | $379K | Hold |
|
|||||
|
2018
Q4 | $435K | Sell |
|
|||||
|
2018
Q3 | $5.01M | Sell |
|
|||||
|
2018
Q2 | $15.7M | Buy |
|
|||||
|
2018
Q1 | $22.9M | Buy |
|
|||||
|
2017
Q4 | $505K | Hold |
|
|||||
|
2017
Q3 | $385K | Buy |
|
|||||
|
2017
Q2 | $331K | Buy |
|
|||||
|
2017
Q1 | $224K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $9.55K | Sell |
|
|||||
|
2016
Q2 | $9.2M | Buy |
|
|||||
|
2016
Q1 | $10.7M | Buy |
|
|||||
|
2015
Q4 | $9.97M | Buy |
|
|||||
|
2015
Q3 | $6.58M | Buy |
|
|||||
|
2015
Q2 | $15.3M | Buy |
|
|||||
|
2015
Q1 | $4.62M | Buy |
|